{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:12:38Z","timestamp":1788588758962,"version":"build-2803163510"},"reference-count":92,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mortality after aneurysmal subarachnoid hemorrhage (aSAH) is augmented by rebleeding and delayed cerebral ischemia (DCI). A range of assays evaluating the dynamic process of blood coagulation, from activation of clotting factors to fibrinolysis, has emerged and a comprehensive review of hemostasis and fibrinolysis following aSAH may reveal targets of treatment. We conducted a systematic review of existing literature assessing coagulation and fibrinolysis following aSAH, but prior to treatment. PubMed, Embase, and Web of Science were searched on November 18, 2020, without time boundaries. In total, 45 original studies were eventually incorporated into this systematic review, divided into studies presenting data only from conventional or quantitative assays (n\u2009=\u200922) and studies employing dynamic assays (n\u2009=\u200923). Data from conventional or quantitative assays indicated increased platelet activation, whereas dynamic assays detected platelet dysfunction possibly related to an increased risk of rebleeding. Secondary hemostasis was activated in conventional, quantitative, and dynamic assays and this was related to poor neurological outcome and mortality. Studies systematically investigating fibrinolysis were sparse. Measurements from conventional or quantitative assays, as well as dynamic fibrinolysis assays, revealed conflicting results with normal or increased lysis and changes were not associated with outcome. In conclusion, dynamic assays were able to detect reduced platelet function, not revealed by conventional or quantitative assays. Activation of secondary hemostasis was found in both dynamic and nondynamic assays, while changes in fibrinolysis were not convincingly demonstrable in either dynamic or conventional or quantitative assays. Hence, from a mechanistic point of view, desmopressin to prevent rebleeding and heparin to prevent DCI may hold potential as therapeutic options. As changes in fibrinolysis were not convincingly demonstrated and not related to outcome, the use of tranexamic acid prior to aneurysm closure is not supported by this review.<\/jats:p>","DOI":"10.1055\/s-0041-1730346","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T19:21:49Z","timestamp":1626290509000},"page":"356-381","source":"Crossref","is-referenced-by-count":7,"title":["Hemostasis and Fibrinolysis following Aneurysmal Subarachnoid Hemorrhage: A Systematic Review on Additional Knowledge from Dynamic Assays and Potential Treatment Targets"],"prefix":"10.1055","volume":"48","author":[{"given":"Christine Lodberg","family":"Hvas","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Mette","family":"Hvas","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"},{"name":"Thrombosis and Hemostasis Research Unit, Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000346087","article-title":"European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage","volume":"35","author":"T Steiner","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0140-6736(16)30668-7","article-title":"Spontaneous subarachnoid haemorrhage","volume":"389","author":"R L Macdonald","year":"2017","journal-title":"Lancet"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1227\/01.neu.0000430290.93304.33","article-title":"The epidemiology of admissions of nontraumatic subarachnoid hemorrhage in the United States","volume":"73","author":"F Rincon","year":"2013","journal-title":"Neurosurgery"},{"issue":"19","key":"ref4","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1212\/WNL.0b013e3181dd42b3","article-title":"Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review","volume":"74","author":"C E Lovelock","year":"2010","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s13054-015-1036-0","article-title":"Subarachnoid hemorrhage: who dies, and why?","volume":"19","author":"H Lantigua","year":"2015","journal-title":"Crit Care"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.mayocp.2018.06.027","article-title":"Time trends in outcomes after aneurysmal subarachnoid hemorrhage over the past 30 years","volume":"93","author":"B La Pira","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11910-019-0990-3","article-title":"Early brain injury after poor-grade subarachnoid hemorrhage","volume":"19","author":"V Rass","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12028-011-9581-0","article-title":"Rebleeding after aneurysmal subarachnoid hemorrhage","volume":"15","author":"R M Starke","year":"2011","journal-title":"Neurocrit Care"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(20)32518-6","article-title":"Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial","volume":"397","author":"R Post","year":"2021","journal-title":"Lancet"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1055\/s-0037-1604089","article-title":"Evidence for the use of tranexamic acid in subarachnoid and subdural hemorrhage: a systematic review","volume":"43","author":"T Anker-M\u00f8ller","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11883-017-0690-x","article-title":"Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology","volume":"19","author":"J R Geraghty","year":"2017","journal-title":"Curr Atheroscler Rep"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1177\/0271678X20921974","article-title":"Microvascular platelet aggregation and thrombosis after subarachnoid hemorrhage: a review and synthesis","volume":"40","author":"J V Clarke","year":"2020","journal-title":"J Cereb Blood Flow Metab"},{"issue":"04","key":"ref13","first-page":"CD006184","article-title":"Antiplatelet therapy for aneurysmal subarachnoid haemorrhage","author":"S M Dorhout Mees","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"09","key":"ref14","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1161\/01.STR.0000236841.16055.0f","article-title":"Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study","volume":"37","author":"W M van den Bergh","year":"2006","journal-title":"Stroke"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1212\/WNL.54.4.872","article-title":"Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage","volume":"54","author":"J W Hop","year":"2000","journal-title":"Neurology"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3171\/jns.1995.82.6.0945","article-title":"Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"82","author":"S Juvela","year":"1995","journal-title":"J Neurosurg"},{"issue":"06","key":"ref17","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/STROKEAHA.108.528802","article-title":"Effect of antiplatelet therapy for endovascular coiling in aneurysmal subarachnoid hemorrhage","volume":"40","author":"W M van den Bergh","year":"2009","journal-title":"Stroke"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-021-01477-6","article-title":"Effects of post-interventional antiplatelet therapy on angiographic vasospasm, delayed cerebral ischemia, and clinical outcome after aneurysmal subarachnoid hemorrhage: a single-center experience","author":"C Ditz","year":"2021","journal-title":"Neurosurg Rev"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/01.STR.23.2.205","article-title":"The international cooperative study on the timing of aneurysm surgery. the North American experience","volume":"23","author":"E C Haley Jr","year":"1992","journal-title":"Stroke"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(05)67214-5","article-title":"International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion","volume":"366","author":"A J Molyneux","year":"2005","journal-title":"Lancet"},{"issue":"05","key":"ref21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MOH.0000000000000074","article-title":"Global assays of hemostasis","volume":"21","author":"K E Brummel-Ziedins","year":"2014","journal-title":"Curr Opin Hematol"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MCG.0000000000001327","article-title":"Interpreting hemostatic profiles assessed with viscoelastic tests in patients with cirrhosis","volume":"54","author":"T Lisman","year":"2020","journal-title":"J Clin Gastroenterol"},{"issue":"02","key":"ref23","first-page":"178","article-title":"Decreased plasma fibrinolytic potential as a risk for venous and arterial thrombosis","volume":"43","author":"T Lisman","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.3390\/mps3040067","article-title":"Fibrin clot formation and lysis in plasma","volume":"3","author":"J B Larsen","year":"2020","journal-title":"Methods Protoc"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1160\/TH16-11-0834","article-title":"Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage","volume":"117","author":"M Kumar","year":"2017","journal-title":"Thromb Haemost"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2016.06.002","article-title":"Increased serum concentrations of signal peptide-Cub-EGF domain-containing protein-1 in patients with aneurysmal subarachnoid hemorrhage","volume":"459","author":"Y S Ding","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"01","key":"ref29","first-page":"1342","article-title":"The changes of von Willebrand factor\/a disintegrin-like and metalloprotease with thrombospondin type I repeats-13 balance in aneurysmal subarachnoid hemorrhage","volume":"8","author":"Q F Tang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2176\/nmc.51.745","article-title":"Prediction of mortality by hematological parameters on admission in patients with subarachnoid hemorrhage","volume":"51","author":"N Sadamasa","year":"2011","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3171\/jns.2005.102.5.0882","article-title":"Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage","volume":"102","author":"Y Hirashima","year":"2005","journal-title":"J Neurosurg"},{"issue":"09","key":"ref32","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s00701-020-04455-x","article-title":"Predictors of deep-vein thrombosis in subarachnoid hemorrhage: a retrospective analysis","volume":"162","author":"F Geraldini","year":"2020","journal-title":"Acta Neurochir (Wien)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/j.wneu.2019.08.155","article-title":"reduced admission serum fibrinogen levels predict 6-month mortality of poor-grade aneurysmal subarachnoid hemorrhage","volume":"136","author":"B Xie","year":"2020","journal-title":"World Neurosurg"},{"issue":"07","key":"ref34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/00207454.2019.1702546","article-title":"High intracranial pressure may be the initial inducer of elevated plasma D-dimer level after aneurysmal subarachnoid haemorrhage","volume":"130","author":"D D Zhao","year":"2020","journal-title":"Int J Neurosci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"8759231","DOI":"10.1155\/2019\/8759231","article-title":"Evaluation of vascular endothelial growth factor A and selected parameters of coagulation and fibrinolysis in a group of patients with subarachnoid haemorrhage","volume":"2019","author":"M Wici\u0144ski","year":"2019","journal-title":"BioMed Res Int"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.4103\/1673-5374.221158","article-title":"D-dimer may predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage: a retrospective study","volume":"12","author":"J H Liu","year":"2017","journal-title":"Neural Regen Res"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"654","DOI":"10.5604\/12321966.1226862","article-title":"Evaluation of VCAM-1 and ICAM-1 concentration and values of global tests concerning the coagulation system of patients suffering from subarachnoid haemorrage","volume":"23","author":"A S Al-Drawi","year":"2016","journal-title":"Ann Agric Environ Med"},{"issue":"06","key":"ref38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2176\/nmc.oa2013-0006","article-title":"Changes in the coagulation and fibrinolytic system of patients with subarachnoid hemorrhage","volume":"54","author":"Y Ji","year":"2014","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"04","key":"ref39","first-page":"296","article-title":"Assessment of the haemostatic system in patients surgically treated for ruptured cerebral aneurysm","volume":"41","author":"R Morga","year":"2007","journal-title":"Neurol Neurochir Pol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/3-211-30714-1_17","article-title":"Changes in coagulative and fibrinolytic activities in patients with intracranial hemorrhage","volume":"96","author":"T Ebihara","year":"2006","journal-title":"Acta Neurochir Suppl (Wien)"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/003655102317475452","article-title":"Blood coagulation and fibrinolysis in acute ischaemic and haemorrhagic (intracerebral and subarachnoid haemorrhage) stroke: does decreased plasmin inhibitor indicate increased fibrinolysis in subarachnoid haemorrhage compared to other types of stroke?","volume":"62","author":"J Antovic","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0090-3019(01)00402-5","article-title":"A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with Hunt-Hess grade and outcome","volume":"55","author":"P Nina","year":"2001","journal-title":"Surg Neurol"},{"issue":"06","key":"ref43","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.STR.31.6.1256","article-title":"Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fibrinolytic system","volume":"31","author":"T Sasaki","year":"2000","journal-title":"Stroke"},{"issue":"02","key":"ref44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3171\/jns.1997.87.2.0207","article-title":"Hemostasis and fibrinolysis activation after subarachnoid hemorrhage","volume":"87","author":"S Peltonen","year":"1997","journal-title":"J Neurosurg"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF02747193","article-title":"Plasma levels of protein C, protein S, and antithrombin III in patients with subarachnoid haemorrhage","volume":"139","author":"K Kanamaru","year":"1997","journal-title":"Acta Neurochir (Wien)"},{"issue":"04","key":"ref46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/02688699209023789","article-title":"Does thrombin prevent cerebral vasospasm following aneurysmal subarachnoid haemorrhage?","volume":"6","author":"P O'Neill","year":"1992","journal-title":"Br J Neurosurg"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/01.STR.23.10.1404","article-title":"Hematogenous factors and prediction of delayed ischemic deficit after subarachnoid hemorrhage","volume":"23","author":"S F Ameriso","year":"1992","journal-title":"Stroke"},{"issue":"04","key":"ref48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/01.STR.7.4.337","article-title":"Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke","volume":"7","author":"A P Fletcher","year":"1976","journal-title":"Stroke"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3171\/jns.1996.84.1.0035","article-title":"Ultra-early rebleeding in spontaneous subarachnoid hemorrhage","volume":"84","author":"Y Fujii","year":"1996","journal-title":"J Neurosurg"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1227\/00006123-199508000-00006","article-title":"Hemostasis in spontaneous subarachnoid hemorrhage","volume":"37","author":"Y Fujii","year":"1995","journal-title":"Neurosurgery"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3171\/jns.1997.86.4.0594","article-title":"Serial changes of hemostasis in aneurysmal subarachnoid hemorrhage with special reference to delayed ischemic neurological deficits","volume":"86","author":"Y Fujii","year":"1997","journal-title":"J Neurosurg"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.2147\/NDT.S229284","article-title":"Thromboelastography with platelet mapping detects platelet dysfunction in patients with aneurysmal subarachnoid hemorrhage with rebleeding","volume":"15","author":"Q He","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.thromres.2020.02.012","article-title":"Ex vivo effect of hemostatic therapy in subarachnoid and intracerebral hemorrhage","volume":"189","author":"C L Hvas","year":"2020","journal-title":"Thromb Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/j.wneu.2019.06.019","article-title":"Thromboelastometry shows early hypercoagulation in patients with spontaneous subarachnoid hemorrhage","volume":"130","author":"S V Lauridsen","year":"2019","journal-title":"World Neurosurg"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/j.wneu.2018.10.035","article-title":"Activation of blood coagulation after aneurysmal subarachnoid hemorrhage: a prospective observational trial of rotational thromboelastometry","volume":"122","author":"A S Vahtera","year":"2019","journal-title":"World Neurosurg"},{"issue":"03","key":"ref56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.STR.1.3.139","article-title":"Coagulation abnormalities in subarachnoid hemorrhage","volume":"1","author":"M G Ettinger","year":"1970","journal-title":"Stroke"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/j.wneu.2017.09.200","article-title":"Coagulation factor hyperfunction after subarachnoid hemorrhage induces deep venous thrombosis","volume":"110","author":"W Miao","year":"2018","journal-title":"World Neurosurg"},{"issue":"07","key":"ref58","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/01.STR.22.7.854","article-title":"Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"22","author":"H Ohkuma","year":"1991","journal-title":"Stroke"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF01400665","article-title":"Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage","volume":"128","author":"Y Hirashima","year":"1994","journal-title":"Acta Neurochir (Wien)"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02187767","article-title":"Anti-phospholipid antibodies and cerebral vasospasm following subarachnoid haemorrhage","volume":"135","author":"Y Hirashima","year":"1995","journal-title":"Acta Neurochir (Wien)"},{"issue":"06","key":"ref61","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3171\/jns.1986.64.6.0907","article-title":"Reduced platelet function in subarachnoid hemorrhage","volume":"64","author":"S A Tsementzis","year":"1986","journal-title":"J Neurosurg"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF01407517","article-title":"Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid","volume":"103","author":"S A Tsementzis","year":"1990","journal-title":"Acta Neurochir (Wien)"},{"issue":"02","key":"ref63","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10143-017-0885-1","article-title":"In vitro analysis of platelet function in acute aneurysmal subarachnoid haemorrhage","volume":"41","author":"C von der Brelie","year":"2018","journal-title":"Neurosurg Rev"},{"issue":"05","key":"ref64","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.thromres.2012.01.016","article-title":"Reduced clot-stability during the first 6\u2009hours after aneurysmal subarachnoid haemorrhage--a prospective case-control study","volume":"129","author":"C C Larsen","year":"2012","journal-title":"Thromb Res"},{"issue":"07","key":"ref65","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MBC.0000000000000845","article-title":"No hyperfibrinolysis following subarachnoid or intracerebral haemorrhage: a prospective cohort study","volume":"30","author":"S V Lauridsen","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/j.wneu.2019.12.109","article-title":"Prospective longitudinal evaluation of coagulation with novel thromboelastography technology in patients after subarachnoid hemorrhage: a pilot study","volume":"136","author":"K El-Khawas","year":"2020","journal-title":"World Neurosurg"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.wneu.2016.04.002","article-title":"Thromboelastography parameter predicts outcome after subarachnoid hemorrhage: an exploratory analysis","volume":"96","author":"P Ramchand","year":"2016","journal-title":"World Neurosurg"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12028-016-0292-4","article-title":"The role of platelet activation and inflammation in early brain injury following subarachnoid hemorrhage","volume":"26","author":"J A Frontera","year":"2017","journal-title":"Neurocrit Care"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jns.2013.08.008","article-title":"Higher levels of coated-platelets are observed in patients with subarachnoid hemorrhage but lower levels are associated with increased mortality at 30 days","volume":"334","author":"C I Prodan","year":"2013","journal-title":"J Neurol Sci"},{"issue":"05","key":"ref70","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MBC.0b013e3283464f53","article-title":"The prognostic value of thrombelastography in identifying neurosurgical patients with worse prognosis","volume":"22","author":"N A Windel\u00f8v","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"03","key":"ref71","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3171\/jns.1973.38.3.0339","article-title":"Monitoring antifibrinolytic therapy in subarachnoid hemorrhage","volume":"38","author":"R R Smith","year":"1973","journal-title":"J Neurosurg"},{"issue":"07","key":"ref72","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years","volume":"90","author":"P M Mannucci","year":"1997","journal-title":"Blood"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0609.1992.tb00906.x","article-title":"DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb\/IIIa","volume":"49","author":"S Lethagen","year":"1992","journal-title":"Eur J Haematol"},{"issue":"01","key":"ref74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-015-0222-x","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine","volume":"24","author":"J A Frontera","year":"2016","journal-title":"Neurocrit Care"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-020-01055-6","article-title":"Effect of desmopressin on platelet dysfunction during antiplatelet therapy: a systematic review","author":"L K Andersen","year":"2020","journal-title":"Neurocrit Care"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3171\/2017.7.JNS17990","article-title":"Desmopressin administration and rebleeding in subarachnoid hemorrhage: analysis of an observational prospective database","volume":"130","author":"C L Francoeur","year":"2019","journal-title":"J Neurosurg"},{"issue":"05","key":"ref77","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/jcbfm.2015.13","article-title":"Hemostasis and fibrinolysis in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review","volume":"35","author":"J Boluijt","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"05","key":"ref78","doi-asserted-by":"crossref","first-page":"E552","DOI":"10.1093\/neuros\/nyaa170","article-title":"Tirofiban protocol protects against delayed cerebral ischemia: a case-series study","volume":"87","author":"M Zanaty","year":"2020","journal-title":"Neurosurgery"},{"issue":"06","key":"ref79","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"E S Connolly Jr","year":"2012","journal-title":"Stroke"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-030-04615-6_3","article-title":"Heparin treatment in aneurysmal subarachnoid hemorrhage: a review of human studies","volume":"127","author":"N K Khattar","year":"2020","journal-title":"Acta Neurochir Suppl (Wien)"},{"issue":"06","key":"ref81","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3171\/jns.2003.99.6.0953","article-title":"No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial","volume":"99","author":"J Siironen","year":"2003","journal-title":"J Neurosurg"},{"issue":"02","key":"ref82","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clineuro.2004.01.006","article-title":"Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo","volume":"106","author":"G Wurm","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3171\/2017.11.JNS17894","article-title":"Continuous infusion of low-dose unfractionated heparin after aneurysmal subarachnoid hemorrhage: a preliminary study of cognitive outcomes","volume":"130","author":"R F James","year":"2018","journal-title":"J Neurosurg"},{"issue":"06","key":"ref84","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3171\/2013.8.JNS1337","article-title":"Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment","volume":"119","author":"J M Simard","year":"2013","journal-title":"J Neurosurg"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fneur.2017.00268","article-title":"High compliance with scheduled nimodipine is associated with better outcome in aneurysmal subarachnoid hemorrhage patients cotreated with heparin infusion","volume":"8","author":"A Wessell","year":"2017","journal-title":"Front Neurol"},{"issue":"07","key":"ref86","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/neurintsurg-2016-012925","article-title":"Effect of heparin on secondary brain injury in patients with subarachnoid hemorrhage: an additional \u2018H\u2019 therapy in vasospasm treatment","volume":"9","author":"M Bruder","year":"2017","journal-title":"J Neurointerv Surg"},{"issue":"02","key":"ref87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12028-011-9605-9","article-title":"Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference","volume":"15","author":"M N Diringer","year":"2011","journal-title":"Neurocrit Care"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/bmj.1.6118.945","article-title":"Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?","volume":"1","author":"R S Maurice-Williams","year":"1978","journal-title":"BMJ"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00701-011-1179-y","article-title":"Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis","volume":"154","author":"T Gaberel","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/jth.14160","article-title":"Hemorrhagic disorders of fibrinolysis: a clinical review","volume":"16","author":"J L Saes","year":"2018","journal-title":"J Thromb Haemost"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1718924","article-title":"Fibrinolysis in patients with liver disease","author":"F A von Meijenfeldt","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"ref92","first-page":"125","volume-title":"Clinical application of fibrinolytic assays","author":"D Pepperell","year":"2014"},{"issue":"03","key":"ref93","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1227\/00006123-198209000-00001","article-title":"Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension","volume":"11","author":"N F Kassell","year":"1982","journal-title":"Neurosurgery"},{"issue":"04","key":"ref94","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00134-018-5086-z","article-title":"Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations","volume":"44","author":"M Oddo","year":"2018","journal-title":"Intensive Care Med"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1730346.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T19:46:05Z","timestamp":1649792765000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1730346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":92,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2022,4,12]]},"published-print":{"date-parts":[[2022,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1730346","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}